Azepinobisindole derivatives, the isomeric Iheyamine skeleton, were prepared and their anticancer activity evaluation were investigated against two human cancer cell lines, Hepatocellular carcinoma (HepG2) and human cervical cancer line (HeLa) as well as the normal cell line (Vero cell line) using MTT assay. The anticancer activity results indicated that 2-methoxy-5-methyl-5H-azepino [2,3-b:4,5-b]diindole was the most active derivative against tested cell lines. Additionally, molecular docking study in silico the possible inhibitory effect of cyclin-dependent kinase 2 (CDK2) by the azepinoindole revealed that all synthesized compounds fit well in the binding cavity of CDK2.
INTROdUCTION
Bisindole alkaloids constitute an important class of secondary metabolites with characteristic cytotoxicity and pharmacological activities. [1] [2] [3] [4] [5] Azepinobisindole alkaloids are a class of bisindole alkaloids containing a structural moiety of azepine (seven-membered ring) core, which demonstrated diverse biological activities especially anticancer effect. In the past years, number types of indole-fused azepines have been found with potential success in drug discovery. For example, Hyrtimomine A was reported to show anticancer activity against human epidermoid carcinoma KB cells and murine leukemia L1210 cells and showed antimicrobial activity against Candida albicans and Cryptococcus neoformans by Tanaka et al., 6 Another example was Trigonoliimines C, which was reported with a modest anti-HIV-1 activity 7 and the anticancer activity against human cervical cancer HeLa cells and human histiocytic lymphoma U-937 cells was also reported by Han et al., 8 As illustrated in Fig. 1 , Iheyamine A (1), the azepinobisindole isolated from a colonial marine ascidian Polycitorella sp. by Sasaki et al., was reported to exhibit moderately cytotoxicity against murine leukemia P388 cells, human lung carcinoma A549 cells and human colon adenocarcinoma HT29 cells with IC 50 in the level of 1 µg/mL. 9 The synthesis of Iheyamine A was firstly accomplished by Lindsay et al., using cross-Mannich reaction. 10 Recently, Abe and Yamada accomplished the synthesis of Iheyamine A via dehydrative Mannich-type reaction. 11 Moreover, Bremner et al., synthesized the 5H-azepino[2,3-b:4,5-b]-diindole system, which was the isomer of Iheyamine A. 12 However, these structure motifs have not been studied for biological activities and their core structure resemble to Hytimomine A, which could be giving promising result for anticancer activity. Therefore, a series of 5H-azepino[2,3-b:4,5-b]-diindole was synthesised and evaluated for cytotoxic activity. Molecular docking study against cyclic-dependent kinase 2 (CDK2) were also investigated the inhibitory ability of the designed compounds as well as the understanding of the antitumor results.
Mass spectra were determined on a POLARIS Q or HEWLETT PACKARD 5973.
Synthesis method
Isatin was purchased from FlukaTM and 5-substituted isatins (2b-d) were prepared according to Sandmeyer isatin synthesis method. 13 general procedure for synthesis of 3a-g Isatin or 5-substituted isatin (7 mmol) and K 2 CO 3 (10 mmol) were added to a dry CH 3 CN solution (25 mL) and stirred for 30 min at RT. Methyl iodide or benzyl chloride (7.5 mmol) was added to the solution and then refluxed at 80°C for 3 hour. The mixture was cooled to RT and the solvent was removed. The residue was dissolved in CH 2 Cl 2 (30 mL) and then washed with H 2 O (3x30 mL). The organic extracts were dried over anh Na 2 SO 4 and concentrated to give the crude brown solid. The purification of the crude solid using flash-column chromatography (silica gel, hexane/EtOAc (2:1) gave the pure compounds 3a-g.
N-methylisatin (3a)
Orange 
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general Methods
Melting points were determined with a Stuart Scientific SMP 2 melting point apparatus and were uncorrected. FT-IR spectra were recorded using a Perkin Elmer Spectrum 100. NMR spectra were recorded on a Bruker Advance 300 (300 MHz for proton NMR and 75 MHz for carbon NMR) using tetramethylsilane (TMS) as an internal reference. general procedure for synthesis of 5a-g N-substituted isatin (3a-g) (0.9 mmol) and tryptamine (4) (1 mmol) in EtOH (5mL) in the presence of (0.2 mL) glacial acetic acid and 4 Å molecular sieve were stirred at RT for 24 hours. The precipitate was removed by filtration and the filtrate was concentrated and purified by column chromatography (silica gel, hexane/EtOAc (2:1) to give compounds 5a-g. 
Spiro[(1-benzyl-3H-indole-2(1H)-one)-3,1'-(1',2',3',4'-tetrahydro-9H-pyrido[3,4-b]indol)] (5e)
Cream general procedure for synthesis of 7a-g A solution of spiroindolone (5a-g) (0.3 mmol) in dry toluene (6 mL) was stirred and cooled to -78°C under Ar atmosphere and DIBAL-H (3 mmol) was added dropwise into the solution. After 4 h, a solution of 5% aqueous NaOH (8 mL) was quenched to the mixture and extracted with EtOAc (3x15 mL). The organic extracts were combined and washed with brine, dried over anhydrous sodium sulfate and after that concentrated under reduced pressure to give oxyindoline 6a-g. (This compound was unstable and used without further purification due to the color changed on a silica gel and in CDCl 3 .)
Spiro[(5-methoxy-1-benzyl-3H-indole-2(1H)-one)-3,1'-(1',2',3',4'-tetrahydro-9H-pyrido[3,4-b]indol)] (5f)
The oxyindoline (6a-g) was warmed in 5M HCl (10 mL) for 1 h at 90°C and then basified with 25% KOH until the pH was more than 12. The solid was filtered and purified by column chromatography (silica gel) to give isomeric Iheyamine derivatives 7a-g. 
5-methyl-5H-azepino
2-bromo-5-methyl-5H-azepino
Anticancer activity Cell culture
Herein, human cervical cancer cells (HeLa), human hepatocellular carcinoma cells (HepG2) and kidney epithelial cells from African green monkey (Vero) were cultured in 10% Fetal Bovine Serum (FBS supplemented DMEM (Dulbecco's Modified Eagle's Medium) and antibiotics. Cells were kept in a humidified 5% CO 2 atmosphere at 37°C with medium changes every 2 days until cells grown to 80-85% confluency. They were collected by trypsinization procedure with 0.25% trypsin and the viable cells were counted by tryphan blue exclusion.
determination of anticancer activity by MTT assay
Cells were seeded on 96-well plate at a density of 1x105 cells/mL. After 24 h, the cells were administered with the test compounds at various concentrations and 20% organic solvent (acetone or DMSO) was used as a positive control. After incubation for 24 h, 100 µL of MTT (400 µg/ mL) was added to each well and further incubated for 4 hours. The medium was then removed and 100 µL of DMSO, which was used to dissolve the resulting formazan crystal, was added to each well. The microplate spectrometer (biochrom EZ Read Where Abs sample was the absorbance of the test compound, Abs control was the absorbance of 1% organic solvent in medium and Abs blank was the absorbance of 20% organic solvent in medium. The IC 50 value was determined by plotting percentage cell viability versus sample concentration.
RESULTS ANd dISCUSSION
Chemistry
The isatin (2a) was purchased from SigmaAldrich and the 5-substituted isatins (2b-d) were prepared by classical Sandmeyer isatin synthesis methods.
13 N-alkylation of isatins (2a-d) with alkyl halide in the presence of K 2 CO 3 were completed the N-substituted isatin derivatives (5a-g) in 52-92% yield (scheme 1).
(7a-g) were compared to the previous synthesis isomeric Iheyamines 12 (scheme 2). 
Scheme 1. Synthesis of N-substituted isatin derivatives (3a-g)
The condensation reaction of N-substituted isatin derivatives (3a-g) with tryptamine (4) under acidic conditions forming the iminium ion intermediate, followed by spiro cyclization to provided racemic spiroindolone (5a-g) in good yield. Based on literature, the partial reduction of spiroindolones were achieved cleanly to the corresponding carbinolamines using sodium bis(2-methoxyethoxy) aluminium hydride. 20 However, the partial reduction using DIBAL-H in handed gave the carbinolamine (6a-g) in low yields. The carbinolamine (6a-g) were used without further purification by heating in 5 M HCl at 90°C to undergo rearrangement to the azepinodiindole (7a-g) and yields were reported from a 2-step process. The structure of compounds 
Anticancer activity
The in vitro anticancer activity of the synthesized compounds (7a-g) were evaluated for cytotoxicity against HeLa, HepG2, and Vero cell lines by MTT assay. 21 All of the tested compounds exhibited good activity against both cancer cell lines and the IC 50 values were shown in Table 1 . The N-methyl derivative of azepinodiindoles (7a-c) were more potent than the N-benzyl derivatives (7e-g). The methoxy substituent on the aromatic ring of compound (7b) and bromine substituent (7c) had similar inhibitory effect against HepG2 and HeLa cell lines with the same IC 50 value of 15.91 µg/ mL. However, compound (7b) had lower activity on normal cell lines (Vero cell lines). The unsubstituted aromatic ring of azepinodiindoles (7a) and (7e) showed the selective inhibitory effect against HepG2 cell lines with no effect from the R 2 substitution. On the aromatic ring, the electron withdrawing nitro group, (7d) was the least active compound compared with other compounds containing methyl groups on R 2 .
Molecular docking
Using the iGEMDOCK v2.1 software 22 , molecular docking was performed in order to explore binding positions along with intermolecular interactions between compounds (7a-g) and binding site of cyclin-dependent kinase 2 (CDK2) which was key protein for cell cycle progression. 23, 24 Compounds (7a-g) were docked into the active site of CDK2 co-crystallized with LZ8 (PDB ID: 2VTO). LZ8 was also redocked into the CDK2 and its binding energy and hydrogen bond was then compared to those of azepinodiindoles (7a-g). The docking results revealed that the binding position of redocked LZ8 (shown in orange in Fig. 2 ) was more or less the same to that of co-crystallized LZ8 in CPX2. Table  2 showed that the binding energy of all synthesized compounds (7a-g) were -103.98 to -84.35 kcal/ mol, which were higher than that of LZ8. Among these, compound 7b fit well in the binding cavity of CPK2 and had the most similar orientation and binding position to those of LZ8, as illustrated in Fig. 2 . Additionally, this compound had three hydrogen bonding interaction with LEU83, LYS89 and GLN131. For 7a, 7c and 7d, it was found that they fit in the binding site of CPK2, however their orientation and binding pose were rather different to those of LZ8 (Fig. 3a) . In contrast, although the azepinodiindoles (7e-g) containing Bn group for R 2 substituent had lower binding energy than 7b, they could not fit in the binding site of CDK2, especially 7g. 
CONCLUSION
In summar y, syntheses of isomeric Iheyamine A derivatives 7a-g can be prepared from the synthetic isatin derivatives and commercially available tryptamine. There have been achieved in 3-11% overall yield with 4-6 steps. The key reactions including Sandmeyer isatin synthesis method, N-alkylation, condensation, reduction and acidcatalyzed rearrangement. Out of the synthesized compounds 7a-g, compound 7b and 7c exhibited higher cytotoxicity against HeLa cell lines more than other compounds and exhibited cytotoxicity against HepG2 cell lines in similar to compound 7a and 7e but compound 7c is toxic to normal cell lines (Vero). Thus, the substitutions on the isomeric Iheaymine A core structure have to further investigation on their biological activities.
